Mirum Pharmaceuticals Inc
MIRM
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.46B
Close$
$27.50
73.6% downside
Current Fair Value
73.6% downsideOvervalued by 73.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.46 Billion |
|---|---|
| Enterprise Value | $6.47 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 0.49 |
| Outstanding Shares | 58,851,021 |
Return
| Return on Equity | -329.43% |
|---|---|
| Return on Assets | -89.67% |
| Return on Invested Capital | -127.83% |
Valuation & Multiples
| P/E Ratio | -7.78 |
|---|---|
| PEG | -0.15 |
| Price to Sales | 17.39 |
| Price to Book Ratio | 26.08 |
| Enterprise Value to Revenue | 15.79 |
| Enterprise Value to EBIT | -8.19 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 1.37 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$-0.73
Average shareholder expectationRevenue Estimate
$166.03 M
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$-0.74
Average shareholder expectationRevenue Estimate
$166.04 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 7.48% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.21%▼ 131.75% |
|---|---|
| Total Invested | $291.30M▼ 95.37% |
| Investors Holding | 72▼ 246.00% |
ESG Score
No data